|
|||||
|
|
| Postapproval clinical experience in the treatment of Dupuytren’s contracture with collagenase clostridium histolyticum (CCH): the first 1,000 days | |
| 摘 要： | |
| 收稿时间： | CCH (0.58 |
| 本文献已被 SpringerLink 等数据库收录！ | |
|
||||||||||
|
||||||||||
|
||||||||||
|
|
|
|
| 设为首页 | 免责声明 | 关于勤云 | 加入收藏 |
|
Copyright©北京勤云科技发展有限公司 京ICP备09084417号 |